A randomized, open-label, oral single dosing, two-way crossover clinical trial to evaluate the safety and pharmacokinetic profiles of CKD-397 in healthy male subjects
The purpose of this study is to compare the safety and pharmacokinetics profiles of CKD-397 in healthy male volunteers.